Charlotte Jones-Burton
Direktor/Vorstandsmitglied bei BLUEBIRD BIO, INC.
Vermögen: 16 947 $ am 30.04.2024
Aktive Positionen von Charlotte Jones-Burton
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BLUEBIRD BIO, INC. | Direktor/Vorstandsmitglied | 07.03.2022 | - |
| Independent Dir/Board Member | 07.03.2022 | - | |
| Women of Color in Pharma | Gründer | - | - |
| Präsident | - | - |
Karriereverlauf von Charlotte Jones-Burton
Ehemalige bekannte Positionen von Charlotte Jones-Burton
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Corporate Officer/Principal | 24.01.2022 | 02.10.2023 |
Otsuka Pharmaceutical Development & Commercialization, Inc.
 Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Corporate Officer/Principal | - | - |
Otsuka Pharmaceuticals (U.K.) Ltd.
 Otsuka Pharmaceuticals (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceuticals (U.K.) Ltd. operates as an investment holding British company with interests in pharmaceutical preparations. The company is based in Slough, UK. The CEO of the company is Stewart Pearce. | Corporate Officer/Principal | - | - |
Ausbildung von Charlotte Jones-Burton
| Washington University in St. Louis | Undergraduate Degree |
| University of Maryland School of Medicine | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Vereinigtes Königreich | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Health Technology |
Otsuka Pharmaceuticals (U.K.) Ltd.
Otsuka Pharmaceuticals (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceuticals (U.K.) Ltd. operates as an investment holding British company with interests in pharmaceutical preparations. The company is based in Slough, UK. The CEO of the company is Stewart Pearce. | Health Technology |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
| Women of Color in Pharma |
- Börse
- Insiders
- Charlotte Jones-Burton
- Erfahrung
